1. For the preparation of compositions with anti-aging effects
CN201611046133.8 provides a composition with anti-aging effect, so as to increase the elasticity and luster of the skin under this combination, and treat benign prostatic hyperplasia, hypercholesterolemia, arteriosclerosis, erectile dysfunction and menopause, postmenopause Symptom purpose.
In order to achieve the above object, the present invention adopts the following technical solutions: Genistein Supplement has anti-aging effect composition, it is characterized in that, described anti-aging effect composition comprises daidzin, daidzein, Genistein Supplement, genistein and Puerarin, wherein the weight ratio of daidzein, daidzein, genistin, genistein and puerarin is (3*104-7*104):(6-10):(0.8*104-1.5*104) :(1-3):(80-110). The application of the composition of the present invention in the human body can increase the elasticity and luster of the skin. In addition, the composition can be used for skin care, breast care (including breast firming, breast enlargement, and breast wrinkle removal), and treatment of benign prostatic hyperplasia, hypercholesterolemia, arteriosclerosis, erectile dysfunction, and menopausal and postmenopausal symptoms. Used in the manufacture of cosmetics, cosmeceuticals, medicinal products and health care products, functional foods, beverages.
2. Pharmaceutical composition for treating hyperlipidemia and atherosclerosis
CN201710312895.6 provides a pharmaceutical composition for treating hyperlipidemia and atherosclerosis with clear ingredients, controllable quality and significant curative effect. The pharmaceutical composition comprises active components, and the active components are puerarin, daidzin, Genistein Supplement, daidzein, acteosin glucoside, astragaloside II, astragaloside IV, formononetin, mulberry bark Combination of two or more of glycoside A, morin, scopoletin, mulberry ketone C, 1-deoxynojirimycin, kudzu root polysaccharide, astragalus polysaccharide and Morus alba polysaccharide. The pharmaceutical composition can reduce the fat plaque area in the aorta of apoE-/-transgenic mice of atherosclerosis model, and has the effect of regulating hyperlipidemia in mice, and can treat hyperlipidemia and atherosclerosis.